HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon to cut jobs

This article was originally published in The Rose Sheet

Executive Summary

Avon expects to reduce its workforce by 8% over next two years with business transformation initiatives, direct-seller says in March 18 Securities and Exchange Commission filing. Cuts will impact about 3,500 of Avon's nearly 44,000 employees. Avon took a $68.3 mil. after-tax charge in fourth quarter relating to organization realignments and facility closings (1"The Rose Sheet" Feb. 11, 2002, p. 10). Company expects to see annual savings of $30 mil. beginning in 2002 from the restructuring. Avon spent $97.2 mil. on advertising in 2001, up 5.2% over 2000 levels; while R&D expenditures rose 6.5% to $45.9 mil...

You may also be interested in...



Avon To Triple R&D Investment; Open “State-Of-The-Art” Research Facility

Avon is increasing its R&D spending by more than $100 mil. from 2002 through 2005, marking the direct-seller's largest R&D budget increase, the company announced May 23

Avon BeComing Prudent; Curbing Plans For U.S. Retail Initiative In 2002

Avon has put a hold on plans to immediately pursue a new retail partner for beComing and expand the brand to additional J.C. Penney doors, CEO Andrea Jung said during the firm's fourth quarter and year-end analyst call Feb. 6

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010134

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel